NOVEL STRATEGIES (FKA) PRISM GROUP

Lobbying for GENEVANT SCIENCES, INC. · Business/legal/admin.for tech-focused nucleic acid development and delivery company

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · Massachusetts · House · Senate · $30,000.00 income · posted Aug 5, 2026

Lobbying activity 1

Matters pertaining to patent law.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.